(Human Chorionic Gonadotropin Hormone 5000 I.U Injection)
HUMUNIS Injection contains Human Chorionic Gonadotropin Hormone. It is a hormone produced by the cells that surround the growing human embryo. These cells eventually form the placenta. Human Chorionic Gonadotropin is detected in the urine from 7-9 days post-fertilisation as the embryo attaches and implants in the womb.
It is important that the corpus luteum keeps producing progesterone because loss of progesterone leads to menstruation, which would prevent an embryo from implanting. HCG is a embryonic hormone which ensures the corpus luteum continues to produce progesterone throughout the first trimester of pregnancy.
1-2 HUMUNIS Injections to induce ovulation, following treatment with an FSH (Follicle Stimulating Hormone) or HMG (Human Menopausal Gonadotrophins) preparation.
Hypogonadotrophic hypogonadism: 1-2 HUMUNIS Injections 2-3 times weekly.
Selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males.
Induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure, and who has been appropriately pretreated with human menotropins.
HCG is an important tumor marker especially (with clinical significance) in Gestational trophoblastic disease.
In the male, hCG injections are used to stimulate the leydig cells to synthesize testosterone. The intratesticular testosterone is necessary for spermatogenesis from the sertoli cells. Typical uses for hCG in men include hypogonadism and fertility treatment.